• Aucun résultat trouvé

[PDF] Top 20 Incidence and risk factors of loss to follow-up among HIV-infected children in an antiretroviral treatment program

Has 10000 "Incidence and risk factors of loss to follow-up among HIV-infected children in an antiretroviral treatment program" found on our website. Below are the top 20 most common "Incidence and risk factors of loss to follow-up among HIV-infected children in an antiretroviral treatment program".

Incidence and risk factors of loss to follow-up among HIV-infected children in an antiretroviral treatment program

Incidence and risk factors of loss to follow-up among HIV-infected children in an antiretroviral treatment program

... the risk of LTFU were: sex, age, country of birth, type of hospital of birth, relationship with the caregiver, height-for-age and weight-for- age using growth standard of ... Voir le document complet

11

Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire.

Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire.

... In our cohort, a CD4 count >250 cells/mm 3 was not associated with occurrence of SAEs, including severe hepatotoxicity and/or cutaneous rash, as was the case in most studies conducted ... Voir le document complet

23

Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.

Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.

... cells and clinical stage had been assessed. In sensitivity analysis we used multiple imputations of CD4 cell counts and clinical stage, as described ...inclusion in logistic and ... Voir le document complet

27

Diagnosis, risk factors and management of diabetes mellitus in HIV-infected persons in France: A real-life setting study

Diagnosis, risk factors and management of diabetes mellitus in HIV-infected persons in France: A real-life setting study

... underrepresented in our study (21.8%) compared to the French DM population, in whom the prevalence of obesity is around 41% [ 33 ...]. In a meta-analysis of 44 studies, Nansseu [ ... Voir le document complet

14

Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.

Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.

... monitoring of HCV/HIV-coinfected patients and active promotion of alcohol cessation should be recommended for the prevention of bone ...; HIV ; alcohol ; protease inhibitor ; ... Voir le document complet

5

Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment.

Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment.

... relationship of disease severity, health beliefs and medication adherence among HIV ...with antiretroviral therapy in HIV patients: considerations for psychosocial ... Voir le document complet

19

Prevalence and determinants of HIV shedding in breast milk during continued breastfeeding among Zambian mothers not on antiretroviral treatment (ART)

Prevalence and determinants of HIV shedding in breast milk during continued breastfeeding among Zambian mothers not on antiretroviral treatment (ART)

... AIDS and Viral Hepatitis, AOR = adjusted odds ratio, ART = antiretroviral treatment, ARV = antiretroviral, BMC = breast milk cell, CAV = cell-associated HIV, CD4 = cluster of ... Voir le document complet

9

Behavioral cardiovascular risk factors in HIV-infected people in France: diversity of profiles across groups requires an urgent and tailored preventive approach

Behavioral cardiovascular risk factors in HIV-infected people in France: diversity of profiles across groups requires an urgent and tailored preventive approach

... purpose and do not aim at quantifying a risk exposure (in which case it would be necessary to account for the different contribution of these risk factors to the ... Voir le document complet

35

Universal antiretroviral therapy among pregnant and postpartum HIV-infected women would improve maternal health and decrease postnatal HIV transmission.

Universal antiretroviral therapy among pregnant and postpartum HIV-infected women would improve maternal health and decrease postnatal HIV transmission.

... cohorts in South [2] and West Africa [3] to evaluate mother-to-child transmission (MTCT) risk through breastfeeding ...Similar to the Zvitambo trial, maternal ART was unavailable ... Voir le document complet

5

Follow-up of three large community-based programs to reduce anaemia among children 24-59 months in Ghana, Malawi and Tanzania

Follow-up of three large community-based programs to reduce anaemia among children 24-59 months in Ghana, Malawi and Tanzania

... policy and programs In the late 1990‘s, national anaemia control policies and programs were primarily focused on pregnant women in most developing countries, particularly in terms ... Voir le document complet

388

Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.: early ART initiation in West Africa

Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.: early ART initiation in West Africa

... Follow-up The procedures of the ART initiation phase have been previously described 10,11 .... In summary: at enrolment, patients started either zidovudine (ZDV)-lamivudine (3TC)-efavirenz or ... Voir le document complet

21

Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Côte d'Ivoire.

Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Côte d'Ivoire.

... Methods and Findings In 2001–2005, HIV-infected pregnant women having received in Abidjan, Coˆte d’Ivoire, a peripartum antiretroviral prophylaxis were presented antenatally with ... Voir le document complet

14

en
                                                                    fr

en fr Early antiretroviral treatment in HIV-1-infected infants Traitement précoce des nourrissons vivant avec le VIH-1

... Abstract HIV-1 infection has several distinctive features in children compared to adults, especially (i) the occurrence of the primary infection during a period of high ... Voir le document complet

18

Mortality according to CD4 count at start of combination antiretroviral therapy among HIV positive patients followed for up to 15 years after start of treatment: collaborative cohort study

Mortality according to CD4 count at start of combination antiretroviral therapy among HIV positive patients followed for up to 15 years after start of treatment: collaborative cohort study

... continue to have a substantially increased mortality ratio after three years of treatment (14, ...only an established risk factor for death, but also for poor CD4 recovery ...years ... Voir le document complet

24

Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview.

Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview.

... 1.00-1.79) and greater increases in CD4 cell counts (aOR ...impact of active drug use on the course of HIV disease in Baltimore (USA) [Lucas, ...2006]. In this study, ... Voir le document complet

21

Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action.

Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action.

... Nucleoside and nucleotide analog inhibitors of reverse transcriptase; NNRTI = Non nucleoside analog inhibitors of reverse transcriptase; NS = non- 3 significant ; PI = protease inhibitors; qd = once ... Voir le document complet

60

Tobacco use and its determinants in HIV-infected patients on antiretroviral therapy in West African countries.: Tobacco use in HIV-infected patients in West Africa

Tobacco use and its determinants in HIV-infected patients on antiretroviral therapy in West African countries.: Tobacco use in HIV-infected patients in West Africa

... tobacco and cannabis ...attributed to each patient, in order to dispose of additional information that could not be collected during the ...use of baseline and ... Voir le document complet

10

[Mortality rate of HIV-infected adults on long term combination antiretroviral therapy.]

[Mortality rate of HIV-infected adults on long term combination antiretroviral therapy.]

... Events of Anti-HIV Drugs Study Group. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D ...Counts of 800 Cells/mm3 or Greater After 7 Years ... Voir le document complet

6

The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Côte d'Ivoire.

The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Côte d'Ivoire.

... bias in our main ...consequences of HIV care on households, for several ...able to gather data on one HIV-infected patient per ...household. In households with more than ... Voir le document complet

8

Incidence of ill-health related job loss and related social and occupational factors. The “unfit for the job” study: a one-year follow-up study of 51,132 workers

Incidence of ill-health related job loss and related social and occupational factors. The “unfit for the job” study: a one-year follow-up study of 51,132 workers

... visit”). An “unfit for the job” outcome may be pronounced for several reasons, including but not limited to: (i) a change in an employee’s health status ...returning to work after ... Voir le document complet

14

Show all 10000 documents...